The Journal of Immunology · 1988 · 32 citations · 0 references
Rodent TnfMast Cell DisorderHuman TnfImmune RegulationImmunologyImmunologic MechanismImmunotherapeuticsIl-3-dependent Basophilic/mast CellsImmune SystemImmunotherapyInflammationTnf-resistant Cell LinesCell SignalingAllergyAutoimmune DiseaseGranulocyteAutoimmunityCell BiologyCytokineImmunoglobulin EMedicine
The murine IL-3-dependent mast cell line, PT18-A17, and the rat basophilic leukemia cell line, RBL-2H3, were found to mediate natural cytotoxic (NC) activity via the release of a soluble factor which specifically lysed NC-sensitive WEHI-164 but not NK-sensitive YAC-1 tumor cells. The release of this NC cell-specific cytotoxic factor was enhanced by triggering of both types of cells via IgE receptor bridging. This factor had activity on TNF-sensitive but not TNF-resistant cell lines and could be neutralized by two independently produced polyclonal anti-mouse TNF antisera. It was not neutralized by antibodies against mouse IFN-alpha/beta or IFN-gamma. Moreover, it was not neutralized by a monoclonal or a polyclonal anti-human TNF, demonstrating that the rodent TNF differed antigenically from human TNF. These results indicate that the cytotoxic factor released from a murine IL-3-dependent mast cell line and from a rat basophilic leukemia cell line is immunologically and functionally related to murine TNF.